Zacks Investment Research Upgrades DAVIDE CAMPARI-/S (DVDCY) to Hold

Share on StockTwits

DAVIDE CAMPARI-/S (OTCMKTS:DVDCY) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Wednesday, Zacks.com reports.

According to Zacks, “Davide Campari Milano SpA is engaged in the beverage industry, which has spirits, wines and soft drinks segments. It products includes Aperol, Appleton Estate, Campari, SKYY, Wild Turkey and Grand Marnier. Davide Campari Milano SpA headquartered in Milan, Italy. “

Other equities analysts have also issued reports about the company. Deutsche Bank raised DAVIDE CAMPARI-/S from a “hold” rating to a “buy” rating and set a $9.00 price target for the company in a report on Wednesday, December 5th. Barclays assumed coverage on DAVIDE CAMPARI-/S in a report on Tuesday. They issued an “equal weight” rating for the company.

Shares of DAVIDE CAMPARI-/S stock traded down $0.12 during trading hours on Wednesday, reaching $9.73. The company had a trading volume of 1,625 shares, compared to its average volume of 1,595. DAVIDE CAMPARI-/S has a one year low of $7.23 and a one year high of $10.06. The firm has a market capitalization of $11.20 billion, a P/E ratio of 44.23, a PEG ratio of 5.05 and a beta of 0.64.

DAVIDE CAMPARI-/S Company Profile

Davide Campari-Milano S.p.A., together with its subsidiaries, manufactures and trades in alcoholic and non-alcoholic beverages in the Americas, Europe, the Middle East, Africa, Europe, and the Asia-Pacific. Its product portfolio includes aperitifs, vodka, whisky, tequila, rum, gin, liqueurs, sparkling and still wines, and ready to drink products under approximately 50 brands.

Featured Article: What does earnings per share mean?

Get a free copy of the Zacks research report on DAVIDE CAMPARI-/S (DVDCY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for DAVIDE CAMPARI-/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DAVIDE CAMPARI-/S and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Helleniccoin Price Down 11.7% This Week
Helleniccoin Price Down 11.7% This Week
Ultrapar Participacoes  Share Price Crosses Above 50-Day Moving Average of $5.31
Ultrapar Participacoes Share Price Crosses Above 50-Day Moving Average of $5.31
AcelRx Pharmaceuticals Inc  Expected to Post Quarterly Sales of $1.55 Million
AcelRx Pharmaceuticals Inc Expected to Post Quarterly Sales of $1.55 Million
Zacks: Analysts Expect Agenus Inc  to Post -$0.33 Earnings Per Share
Zacks: Analysts Expect Agenus Inc to Post -$0.33 Earnings Per Share
Sensus Healthcare Inc  Expected to Announce Earnings of -$0.03 Per Share
Sensus Healthcare Inc Expected to Announce Earnings of -$0.03 Per Share
Ultrapar Participacoes  Share Price Crosses Above 50-Day Moving Average of $5.31
Ultrapar Participacoes Share Price Crosses Above 50-Day Moving Average of $5.31


 
© 2006-2019 Zolmax.